Format

Send to

Choose Destination
Microb Biotechnol. 2017 Sep;10(5):1036-1040. doi: 10.1111/1751-7915.12835. Epub 2017 Aug 15.

Roads to advanced vaccines: influenza case study.

Author information

1
Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, D-38124, Braunschweig, Germany.

Abstract

Vaccines represent a cornerstone to ensure healthy lives and promote well-being for all at all ages. However, there are many diseases for which vaccines are not available, are relatively ineffective or need to be adapted periodically. Advances in microbial biotechnology will contribute to overcoming these roadblocks by laying the groundwork for improving and creating new approaches for developing better vaccines, as illustrated here in the case of influenza.

PMID:
28809451
PMCID:
PMC5609253
DOI:
10.1111/1751-7915.12835
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center